| 1. |
?Zumla A, Abubakar I, Raviglione M, et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis, 2012, 205(2):228-240.
|
| 2. |
孟繁榮, 劉志輝, 謝貝, 等.我國利福平敏感結核桿菌rpoB基因利福平耐藥定區序列循證分析.實用醫學雜志, 2009, 29(21):3601-3604.
|
| 3. |
Miller LP, Crawford JT, Shinnick TM. The rpoB gene of Mycobacterium tuberculosis. Ntimicrob Agents Ch, 1994, 38(4):805-811.
|
| 4. |
Palomino J C. Nonconventional and new methods in the diagnosis of tuberculosis:feasibility and applicability in the field. Eur Respir J, 2005, 26(2):339-350.
|
| 5. |
Palomino JC. Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis. Curr Opin Pulm Med, 2006, 12(3):172-178.
|
| 6. |
Isfahani BN, Tavakoli A, Salehi M, et al. Detection of rifampin resistance patterns in Mycobacterium tuberculosis strains isolated in Iran by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing methods. Mem Inst Oswaldo Cruz, Rio de Janeiro, 2006, 101(6):597-602.
|
| 7. |
Scarpellini P, Braglia S, Brambilla AM, et al. Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system. J Clin Microbiol, 1997, 35(11):2802-2806.
|
| 8. |
汪保國, 陳思東, 張勝, 等.結核分支桿菌rpoB基因突變與對利福平耐藥的關系.實用醫學雜志, 2009, 25(7):1022-1024.
|
| 9. |
Whiting P, Rutjes AW, Reitsma IB, 等. QUADAS的制定:用于系統評價中評價診斷性研究質量的工具(譯文).中國循證醫學雜志, 2007, 7(4):296-306.
|
| 10. |
Whiting P, Weswood ME, Rutjes AW, 等. QUADAS評價:一種用于診斷性研究的質量評價工具(修訂版)(譯文).中國循證醫學雜志, 2007, 7(7):531-536.
|
| 11. |
張天嵩, 鐘文昭. Meta Disc軟件在診斷試驗Meta分析中的應用.循證醫學, 2008, 8(2):97-108.
|
| 12. |
楊柳, 蘇明權, 程曉東, 等. PCR-SSCP法檢測結核分枝桿菌耐藥性.第四軍醫大學學報, 2004, 24(23):2142-214.
|
| 13. |
鐘敏, 溫博海.檢測結核分枝桿菌rpoB基因突變的研究.中華檢驗醫學雜志, 2002, 25(1):38-41.
|
| 14. |
褚美芬, 嚴杰, 鐘雅文, 等.快速檢測結核分枝桿菌異煙肼和利福平耐藥相關基因mPCR-SSCP建立及應用.中華微生物學和免疫學雜志, 2012, 32(7):655-660.
|
| 15. |
Cheng X, Zhang J, Yang L, et al. A new Multi-PCR-SSCP assay for simultaneous detection of isoniazid and rifampin resistance in mycobacterium tuberculosis. J Microbiol Meth, 2007, 70:301-305.
|
| 16. |
Telenti A, Honore N, Bernasconi C, et al. Genotypic assessment of isoniazid and rifampin resistance in mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol, 1997, 35(3):719-723.
|
| 17. |
Sheng J, Li J, Sheng G, et al. Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China. J Appl Microbiol, 2008, 105(3):904-911.
|
| 18. |
Negi SS, Rai A, Gupta S, et al. Characterization of rpoB gene for detection of rifampicin drug resistance by SSCP and sequence analysis. Int J Infect Dis, 2008, 12:e318.
|
| 19. |
Mani C, Selvakumar N, Kumar V, et al. Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampicin resistance in mycobacterium tuberculosis. Int J Tuberc Lung D, 2003, 7(7):652-659.
|
| 20. |
Kim BJ, Lee KH, Yun YJ, et al. Simultaneous identification of rifampin-resistant Mycobacterium tuberculosis and nontuberculous mycobacteria by polymerase chain reaction-single strand conformation polymorphism and sequence analysis of the RNA polymerase gene (rpoB). J Microbiol Meth, 2004, 58(1):111-118.
|
| 21. |
Wu X, Zhang J, Zhuang Y, et al. Molecular mechanisms of drug resistance in mycobacterium tuberculosis clinical isolates. CMJ, 1999, 112(6):524-528.
|
| 22. |
Devillé WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies:didactic guidelines. BMC Medical Research Methodology, 2002, 2(1):1-13.
|
| 23. |
柳清云, 孫剛, 高謙.結核分枝桿菌(MTB)異質性耐藥研究進展.復旦學報(醫學版), 2013, 40(1):1-4.
|
| 24. |
Bossuyt PMM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy:Explanation and elaboration. Clin Chem, 2003, 49(1):7-18.
|
| 25. |
Tackmann R'Schuetz G, HammB, et al. Quality of the reporting of diagnostic accuracy studies:STARD (Standards for the Reporting of Diagnostic accuracy studies). Rofo, 2010, 182(8):655-659.
|